CCP
LEGN icon

Clough Capital Partners’s Legend Biotech LEGN Stock Holding History

Clough Capital Partners’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-41,100
Closed -$2.84M – 223
2023
Q2 		$2.84M Sell
41,100
-160,136
-80% -$10.5M 0.29% 95
2023
Q1 		$9.7M Buy
201,236
+162,760
+423% +$7.96M 1.05% 31
2022
Q4 		$1.92M Sell
38,476
-119,749
-76% -$5.8M 0.19% 100
2022
Q3 		$6.46M Buy
158,225
+9,400
+6% +$441K 0.69% 29
2022
Q2 		$8.19M Buy
148,825
+19,134
+15% +$808K 1.02% 32
2022
Q1 		$4.71M Sell
129,691
-65,361
-34% -$2.58M 0.36% 64
2021
Q4 		$9.09M Buy
+195,052
New +$9.89M 0.61% 50

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Clough Capital Partners's LEGN Position: Q3 2023 in Review

Clough Capital Partners sold out of Legend Biotech (LEGN) in Q3 2023, closing a stake of 41,100 shares — an estimated $2.84M sold.

Clough Capital Partners first reported a position in LEGN in Q4 2021 and held it in 7 quarters. The position peaked at $9.7M in Q1 2023. 200 funds tracked by Wall St. Rank hold LEGN as of Q3 2023.

  • Clough Capital Partners reported no remaining Legend Biotech position as of Q3 2023 after selling out during the quarter.
  • Clough Capital Partners sold 41,100 Legend Biotech shares in Q3 2023, an estimated $2.84M.
  • Clough Capital Partners first reported a position in Legend Biotech in Q4 2021 and held it in 7 quarters.
  • Clough Capital Partners's Legend Biotech position peaked at $9.7M in Q1 2023.
  • 200 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2023.

Based on Clough Capital Partners's 13F filing for Q3 2023, filed 14 Nov 2023.